We speculated that CK7, ELF3, EGFR and EphB4 expression in PMBCs are appropriate markers for detecting CTCs and have potential in the evaluation of prognosis and monitoring of therapy in NSCLC. The gene discussed is ELF3; the disease is non-small cell lung carcinoma.